Cullinan Therapeutics To Host An Immunology Day Event in New York City For Analysts And Institutional Investors On June 10
Benzinga Newsdesk 5 months ago
News
New and updated clinical data to be presented from over 30 patients across systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) studiesInitial data from the first multi-dose cohort of RA study to be
New and updated clinical data to be presented from over 30 patients across systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) studies
Initial data from the first multi-dose cohort of RA study to be presented
Initial data from the first multi-dose cohort of velinotamig study also to be shared
Leading key opinion leaders Dr. Ricardo Grieshaber-Bouyer and Dr. John Tesser to share clinical perspectives
The Company will host the in-person event for analysts and institutional investors on Wednesday, June 10, starting at 8:30 a.m. ET in New York City